Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

CM-352 reduces MMP10-driven fibrinolysis in rivaroxaban-associated ICH

July 15, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Limitations of certain mouse models for sickle cell research highlighted

July 8, 2022

New coagulation factor XIa inhibitors discovered at Shanghai Leadingtac Pharmaceutical

July 7, 2022

KalVista Pharmaceuticals patents FXIIa inhibitors

June 29, 2022

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

June 16, 2022

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

At EHA 2022, insights into multiple reasons for marrow failure

June 13, 2022

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.